Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06966206Phase 3Recruiting
Phase 3, randomised, double-blind trial of multiprofen-cc in hand osteoarthritis (2 arms), sponsored by St. Joseph's Healthcare Hamilton. Primary endpoint: Pain intensity at 6 weeks. Started Mar 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06966206.